Biblioteca Digital

**Autoria(s):** Furst D.E.; Keystone E.C.; So A.K.; Braun J.; Breedveld F.C.; Burmester G.R.; De Benedetti F.; Dörner T.; Emery P.; Fleischmann R.; Gibofsky A.; Kalden J.R.; Kavanaugh A.; Kirkham B.; Mease P.; Rubbert-Roth A.; Sieper J.; Singer N.G.; Smolen J.S.; Van Riel P.L.; Weisman M.H.; Winthrop K.L.
Data(s)	2013
Identificador	http://serval.unil.ch/?id=serval:BIB_EFE5644700C1 isbn:1468-2060 (Electronic) pmid:23532441 doi:10.1136/annrheumdis-2013-203348 isiid:000316826300002
Idioma(s)	en
Fonte	Annals of the Rheumatic Diseases, vol. 72, no. Suppl. 2, pp. ii2-i34
Palavras-Chave	#Antibodies, Monoclonal, Humanized/adverse effects; Antibodies, Monoclonal, Humanized/therapeutic use; Antirheumatic Agents/adverse effects; Antirheumatic Agents/therapeutic use; Female; Humans; Immunoconjugates/adverse effects; Immunoconjugates/therapeutic use; Immunosuppressive Agents/adverse effects; Immunosuppressive Agents/therapeutic use; Male; Polyethylene Glycols/adverse effects; Polyethylene Glycols/therapeutic use; Pregnancy; Rheumatic Diseases/complications; Rheumatic Diseases/drug therapy; Treatment Outcome; Tumor Necrosis Factor-alpha/antagonists & inhibitors; Urate Oxidase/adverse effects; Urate Oxidase/therapeutic use
Tipo	info:eu-repo/semantics/review article

Acesso ao item digital